ChartRow logo
Share this page
CME
$293.87+1.52%
as of close, Oct 16, 2026
☾ AH $293.87 +1.52%
PeersJPMHOODBACVBRK-BGS

CME financial statements

The full income statement, balance sheet, and cash-flow statement for CME Group Inc. (CME), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 360.1M2024-09 360.4M2024-12 360.4M2025-03 360.4M2025-06 360.4M2025-09 360.6M2025-12 358.6M2026-03 362.4M2026-06 359.6M-0.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue6.52B+6.4%6.13B+9.9%5.58B+11.1%5.02B+7.0%4.69B-4.0%
Amortization of intangibles223M+0.8%222M-2.2%227M-0.5%228M-4.2%238M-23.7%
Operating income4.23B+7.6%3.93B+14.4%3.44B+13.9%3.02B+14.0%2.65B+0.3%
Interest expense173M+7.8%161M+0.9%159M-2.0%163M-2.5%167M+0.4%
Other non-operating income-4.83B-32.1%-3.66B+22.1%-4.69B-152.1%-1.86B-643.6%343M+379.9%
Equity-method income372M+5.9%351M+18.2%297M-1.4%301M+22.5%246M+29.0%
Pre-tax income5.33B+17.4%4.54B+9.3%4.15B+19.0%3.49B+3.5%3.37B+23.9%
Income tax1.26B+23.9%1.02B+9.5%927M+16.0%799M+8.5%737M+19.7%
4.07B+15.5%3.53B+9.3%3.23B+19.9%2.69B+2.0%2.64B+25.2%
Net income to non-controlling interest——0.000.00-100.0%500K-58.3%
Net income to common4.02B+15.5%3.48B+9.3%3.19B+19.9%2.66B+1.5%2.62B+24.3%
$11.16+15.4%$9.67+9.1%$8.86+19.7%$7.40+1.5%$7.29+24.2%
EPS (basic)$11.18+15.4%$9.69+9.2%$8.87+19.7%$7.41+1.5%$7.30+24.1%
Weighted-avg shares (basic)360M+0.1%359M+0.1%359M+0.1%359M+0.1%358M+0.2%
Weighted-avg shares (diluted)360M+0.1%360M+0.1%360M+0.1%359M+0.1%359M+0.1%
Dividends per share$5.00-51.9%$10.40+7.8%$9.65+13.5%$8.50+44.1%$5.90+0.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
165B+60.5%103B+8.6%94.9B-31.8%139B-14.0%162B+81.2%
Cash & equivalents4.42B+52.7%2.89B-0.7%2.91B+7.1%2.72B-4.0%2.83B+73.6%
Short-term investments125M+10.4%113M+1.3%112M+16.4%96.0M-16.5%115M+14.0%
Accounts receivable639M+11.5%573M+7.0%536M+10.8%483M+11.2%435M-5.8%
Other current assets522M-6.7%559M-50.9%1.14B+114.9%530M+23.8%428M+39.5%
198B+44.4%137B+6.0%130B-25.5%174B-11.5%197B+57.9%
Property, plant & equipment363M-6.1%386M-5.7%410M-10.1%456M-9.9%505M-12.8%
Operating lease right-of-use210M-9.0%231M-15.0%272M-12.4%311M-10.0%345M-11.5%
Goodwill10.5B+0.3%10.5B-0.1%10.5B+0.1%10.5B-0.4%10.5B-2.5%
Intangible assets2.16B-23.4%2.82B-7.5%3.05B-6.7%3.27B-7.4%3.53B-27.4%
Other non-current assets2.40B-32.2%3.54B-3.9%3.69B-0.8%3.71B+13.3%3.28B+67.5%
160B+56.7%102B+9.5%93.4B-32.2%138B-14.2%160B+81.9%
Accounts payable71.8M-10.1%79.9M-11.8%90.6M-25.4%121M+148.8%48.8M-29.6%
Short-term & current debt0.00-100.0%750M0.00-100.0%16.0M-97.9%749M
Current lease liability46.8M+4.7%44.7M-4.3%46.7M-6.4%49.9M+5.5%47.3M+6.3%
Other current liabilities569M-78.0%2.59B-17.4%3.13B+36.2%2.30B+39.4%1.65B+22.6%
Finance lease liability (current)9.00M+3.4%8.70M+3.6%8.40M+2.4%8.20M+3.8%7.90M+2.6%
170B+52.9%111B+7.8%103B-30.1%147B-13.0%169B+72.3%
Non-current lease liability237M-17.9%289M-15.9%344M-10.3%384M-14.7%449M-8.7%
Operating lease liability (total)284M-14.9%334M-14.5%391M-9.9%433M-12.7%497M-7.5%
Finance lease liability (total)50.7M-14.6%59.4M-12.4%67.8M-10.8%76.0M-9.3%83.8M-8.4%
Finance lease liability41.7M-17.8%50.7M-14.6%59.4M-12.4%67.8M-10.7%75.9M-9.4%
Deferred tax liabilities5.24B-0.1%5.25B-1.5%5.33B-0.6%5.36B-0.5%5.39B-3.9%
Other non-current liabilities735M+1.9%721M-9.6%798M-3.4%826M-7.9%897M-15.4%
28.7B+8.5%26.5B-0.9%26.7B-0.5%26.9B-1.9%27.4B+4.0%
Preferred stock0.000.000.000.000.00
Additional paid-in capital22.2B-0.9%22.4B+0.3%22.3B+0.3%22.3B+0.3%22.2B+4.7%
Retained earnings6.43B+53.7%4.19B-6.0%4.46B-6.1%4.75B-7.9%5.15B+3.1%
Accumulated other comprehensive income81.9M+177.6%-106M-89.7%-55.6M+58.3%-133M-349.2%53.5M-60.3%
Non-controlling interest
————0.00-100.0%
Total equity incl. non-controlling
————27.4B+4.0%
Total liabilities & equity198B+44.4%137B+6.0%130B-25.5%174B-11.5%197B+57.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.28B+15.9%3.69B+6.9%3.45B+13.0%3.06B+27.2%2.40B-11.5%
Depreciation & amortization108M-6.6%115M-8.7%126M-6.6%135M-8.7%148M-3.5%
Intangible amortization223M+0.8%222M-2.2%227M-0.5%228M-4.2%238M-23.7%
Share-based compensation94.8M+5.9%89.5M+8.0%82.9M-1.7%84.3M+12.1%75.2M-21.7%
Deferred income taxes-6.10M+90.8%-66.4M+11.5%-75.0M-223.3%-23.2M-166.7%34.8M+183.7%
Change in receivables67.1M+70.3%39.4M-23.5%51.5M+0.8%51.1M+11.8%45.7M+262.1%
Change in payables-8.10M+24.3%-10.7M+65.3%-30.8M-142.5%72.5M+489.8%-18.6M-351.4%
1.50B+1914.5%-82.6M-495.2%20.9M+104.3%-490M-938.7%58.4M+133.3%
Capital expenditure83.5M-11.2%94.0M+23.0%76.4M-14.8%89.7M-29.5%127M-35.6%
Free cash flow4.19B+16.6%3.60B+6.5%3.38B+13.9%2.97B+30.4%2.28B-9.6%
Acquisitions0.000.000.000.000.00
Sales/maturities of investments7.90M+31.7%6.00M+1.7%5.90M-6.3%6.30M-33.0%9.40M-23.6%
Proceeds from sale of PP&E——0.000.00-100.0%39.3M
56.5B+1013.2%5.08B+110.5%-48.3B-90.4%-25.4B-136.3%69.9B+48.0%
Long-term debt issued741M0.000.00-100.0%741M0.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid3.93B+9.7%3.58B+10.8%3.24B+22.9%2.63B+20.3%2.19B+3.8%
Other financing activities-8.70M+5.4%-9.20M+1.1%-9.30M-17.7%-7.90M-154.8%-3.10M-40.9%
Net change in cash62.3B+617.2%8.68B+119.4%-44.9B-96.6%-22.8B-131.5%72.4B+45.4%
Interest paid136M+4.4%130M+0.0%130M-2.5%133M-0.1%133M+0.0%
Income taxes paid1.16B-2.7%1.20B+11.6%1.07B+10.1%973M+28.9%755M+15.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap97.9B+17.0%83.7B+10.4%75.8B+25.3%60.5B-26.3%82.1B+25.6%
P/E24.0×+1.3%23.7×-15.8%28.2×+24.8%22.6×-27.5%31.1×+0.3%
P/S15.0×+10.0%13.7×-3.7%14.2×+16.2%12.2×-30.3%17.5×+30.8%
P/B3.4×+7.9%3.2×+17.3%2.7×+25.8%2.1×-28.5%3.0×+20.8%
P/FCF23.4×+0.4%23.3×+1.6%22.9×+0.3%22.8×-36.8%36.1×+39.0%
Earnings yield4.2%-1.3%4.2%+18.7%3.5%-19.9%4.4%+37.9%3.2%-0.3%
FCF yield4.3%-0.4%4.3%-1.6%4.4%-0.3%4.4%+58.1%2.8%-28.1%
Dividend yield1.8%-59.1%4.5%-2.3%4.6%-9.3%5.1%+95.7%2.6%-20.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: CME’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CME filings on SEC EDGAR → Not investment advice.